Drug intelligence / Profile preview

voacamine

Development stage
Unknown
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral (for Antimalarial Use)
01

Overview

Voacamine is a naturally occurring dimeric indole alkaloid of the secologanin type, found in several plants including Voacanga africana and Tabernaemontana divaricata. It is isolated from the bark of Pescheria fuchsiae folia and has been approved as an antimalarial drug in several African countries. Voacamine exhibits antagonistic activity at the cannabinoid receptor 1 (CB1) and acts as an inhibitor of P-glycoprotein (ABCB1), which is involved in multidrug resistance in tumor cells. It has also been identified as a potential inhibitor of epidermal growth factor receptor (EGFR), showing antiproliferative effects on certain cancer cell lines. Voacamine is under investigation for its ability to modulate multidrug resistance, particularly by sensitizing resistant tumor cells to chemotherapeutics like doxorubicin, without significant toxicity to normal fibroblasts at relevant concentrations[1][2][4][5][7][10].

Other names
voacangininevocamine
02

Targets

CNR1 (Cannabinoid receptor 1)ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on voacamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on voacamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call